Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The aim of this study is to evaluate whether a new test using mannitol infusion can diagnose the cause of polyuria-polydipsia syndrome as accurately as the current standard test (hypertonic saline infusion) and to compare which test patients prefer. The goal is to identify a simpler and more patient-friendly diagnostic approach.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Hypotonic polyuria/polydipsia syndrome defined as polyuria >40ml/kg body weight/24h and polydipsia >3l/24h; and urine osmolality <800mOsm/L or known AVP-D based on accepted criteria
Disqualifiers
Polyuria/polydipsia secondary to diabetes mellitus, hypercalcemia, or hypokalemia
Diagnosis of AVP-R (Copeptin > 21.4 pmol/L)
Evidence of acute illness
Epilepsy requiring treatment
Trial design
Treatments tested in this trial
- Mannitol
- Hypertonic Saline
Treatment groups
144 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov